Atropos Health

Healthcare provider wearing a stethoscope and looking out a window
By  Jessica Hagen 01:22 pm January 5, 2024
California-based real-world data platform Atropos Health announced that healthcare data analytics company Arcadia has joined its health portfolio, giving Arcadia's provider customers and life sciences users access to Atropos' offerings. Atropos Health offers AI innovations, evidence generation, analytics augmentation and data evaluation to help physicians access real-world evidence to guide...
Healthcare providers standing next to each other while wearing blue scrubs and looking at a tablet
By  Jessica Hagen 01:00 pm September 21, 2023
California-based real-world data platform Atropos Health announced it completed a strategic financing round with participation from Sumitomo Corporation Venture Group's Presidio Ventures, Samsung Next, Audere Capital, Gaingels and other investors.  WHAT IT DOES Atropos Health offers AI innovations, evidence generation, analytics augmentation and data evaluation to help physicians access real-...
Healthcare provider standing in a hospital room wearing a pink stethoscope while holding a tablet
By  Jessica Hagen 12:42 pm August 24, 2023
Real-world data platform Atropos Health announced it appointed a life science advisory board and moved into the life sciences sector, offering AI innovations, data evaluation, evidence generation and analytics augmentation.  Atropos' app helps physicians access real-world evidence to guide clinical decisions and research.  The California-based company also offers its Green Button for clinical...
A piggy bank next to a stethoscope and a pile of coins.
By  Emily Olsen 10:16 am August 10, 2022
AI-backed remote monitoring and digital therapeutics company Biofourmis added another $20 million to its Series D round, bringing its raise to $320 million. The extension funding comes from Intel Capital, the strategic investment division of chipmaker Intel. The company first announced its Series D in April, which boosted Biofourmis to unicorn status with a valuation of $1.3 billion. Biofourmis...